Registered Study Will Compare BCI Communication With Eye Tracking in ALS
A registered study that is not yet recruiting will compare a wearable brain-computer interface communication device with the eye-tracking devices already used by people with ALS. It plans to enroll 30 adults who use Tobii Dynavox or Smartbox eye-tracking devices. Each participant will try three options at home over 12 weeks: their own eye-tracking device and Cognixion ONE with either a head-worn augmented-reality display or a screen-based display. The main measure is the time participants voluntarily choose to use each option. Additional measures include communication speed, accuracy, and caregiver burden. No results are available. Cognixion ONE is investigational and is not FDA-approved or cleared for any medical use.